Prot #AV-951-12-205: A Phase 2 Randomized, Double-Blind, Crossover, Controlled, Multi-Center, Subject Preference Study of Tivozanib Hydrochloride Versus Sunitinib in the Treatment of Subjects with Metastatic Renal Cell Carcinoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/19/12 → 10/19/18

Funding

  • AVEO Pharmaceuticals, Inc. (Prot #AV-951-12-205)